Target Margin Theater to Stage DRUNKEN WITH WHAT; Previews Begin in February

Kicking off the 2016 spring season, Target Margin Theater presents a special treatment of Eugene O'Neill's epicMourning Becomes Electra. Drunken With What, presented at the Abrons Arts Center's historic Playhouse in February 2016, is the first in a series of studies of key scenes in the Mourning Becomes Electra trilogy and will offer audiences a deep reflection on the seminal work. Previews will begin on February 11th, 2016 with an opening night set for February 15th, 2016. Tickets will be $30.

"Here is the most massive, vivid, complex drama in American literature; we are taking just a slice of it, to create a short, intense, layered study. Drunken With What is the essence of this great work - a step on the way, as we prepare to take on the full trilogy, with irreverent reverence. Mourning Becomes Electra effectively won O'Neill the Nobel Prize, and people in 1936 weren't stupid. I'm just saying," said Founder/Artistic Director David Herskovits.

Drunken With What is part of Target Margin Theater's two-season exploration of the great father of American theater, Eugene O'Neill. Who was O'Neill? Genius, blowhard, giant of the imagination, ham-fisted avatar of pseudo-psychology, geographer of the human spirit, was he drunk on art or just drunk? He rewrote Greek tragedy, refurbished American melodrama, and reinvented depth psychology for the stage, and TMT brings it all to you.

Target Margin Theater was founded in 1991 by Artistic Director David Herskovits. For 24 years Target Margin has been praised for their aggressive interpretations of classic texts, lesser-known works, and new plays inspired by existing sources. TMT has presented ambitious re-thinkings of plays by Shakespeare, Chekov, Brecht, Gertrude Stein, and Beaumarchais, among others. TMT has also created original works and new music / opera over the years and has served over 1,000 artists (mostly emerging) through its annual LAB. In addition, TMT is committed to nurturing the creative aspirations of the next generation of theater makers in the TMT Institute, our yearlong fellowship program. The company's artistic and cultural vision has resulted in 40 Mainstage productions including 11 world premieres, 8 company-created works, 3 U.S. premieres and 5 new translations, which have garnered 4 OBIE Awards and employed over 500 Equity actors and hundreds of other theater artists. The company's production of Mamba's Daughters received an OBIE Award, and their epic 2004-06 production of Goethe's Faust received extensive critical acclaim. Recent productions include Uncle Vanya and The Tempest at HERE, Uriel Acosta: I Want That Man! at The Chocolate Factory, Composition...Master-Pieces...Identity, a new solo performance piece from OBIE Award-winner David Greenspan at The Connelly Theater, and, most recently, Reread Another at The Brick, called "something kind of wonderful" by Ben Brantley in The New York Times.

TMT's programming is made possible through major support from The Andrew W. Mellon New York Theater Program, A.R.T. / NY Creative Space Grant, the Axe-Houghton Foundation, The Barbara Bell Cumming Foundation, Charina Foundation, The Clinton Walker Family Foundation, The Edith Lutyens and Norman Bel Geddes Design Enhancement Fund, The Fan Fox & Leslie R. Samuels Foundation, Fred Alger Management, Inc., The Harold and Mini Steinberg Charitable Trust, the Howard Gilman Foundation, the Iger Bay Foundation, the Jerome Robbins Foundation, the New York City Department of Cultural Affairs, New York State Council on the Arts and The Shubert Foundation.

To post a comment, you must register and login.